Surgical oncology
Validation of a prognostic calculator to predict recurrence and mortality in melanoma patients undergoing sentinel lymph node biopsy.
Julia Downey, Christopher Baliski
Published: 202510.1016/j.suronc.2025.102311
Abstract
BACKGROUND: The American Joint Committee on Cancer staging system (AJCC) is currently the gold standard for determining melanoma prognosis. However, it may not accurately reflect survival in certain substages, nor recurrence risk, prompting developme…
Preview only. Read the full abstract at the source